Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

355 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Feasibility, safety, and efficacy of the combination of D-serine and computerized cognitive retraining in schizophrenia: an international collaborative pilot study.
D'Souza DC, Radhakrishnan R, Perry E, Bhakta S, Singh NM, Yadav R, Abi-Saab D, Pittman B, Chaturvedi SK, Sharma MP, Bell M, Andrade C. D'Souza DC, et al. Among authors: bhakta s. Neuropsychopharmacology. 2013 Feb;38(3):492-503. doi: 10.1038/npp.2012.208. Epub 2012 Oct 24. Neuropsychopharmacology. 2013. PMID: 23093223 Free PMC article. Clinical Trial.
Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans.
D'Souza DC, Braley G, Blaise R, Vendetti M, Oliver S, Pittman B, Ranganathan M, Bhakta S, Zimolo Z, Cooper T, Perry E. D'Souza DC, et al. Among authors: bhakta s. Psychopharmacology (Berl). 2008 Jul;198(4):587-603. doi: 10.1007/s00213-007-1042-2. Epub 2008 Jan 29. Psychopharmacology (Berl). 2008. PMID: 18228005 Free PMC article.
Highs and lows of cannabinoid-dopamine interactions: effects of genetic variability and pharmacological modulation of catechol-O-methyl transferase on the acute response to delta-9-tetrahydrocannabinol in humans.
Ranganathan M, De Aquino JP, Cortes-Briones JA, Radhakrishnan R, Pittman B, Bhakta S, D'Souza DC. Ranganathan M, et al. Among authors: bhakta s. Psychopharmacology (Berl). 2019 Nov;236(11):3209-3219. doi: 10.1007/s00213-019-05273-5. Epub 2019 Jun 11. Psychopharmacology (Berl). 2019. PMID: 31187152 Clinical Trial.
The safety of studies with intravenous Δ⁹-tetrahydrocannabinol in humans, with case histories.
Carbuto M, Sewell RA, Williams A, Forselius-Bielen K, Braley G, Elander J, Pittman B, Schnakenberg A, Bhakta S, Perry E, Ranganathan M, D'Souza DC; Yale THC Study Group. Carbuto M, et al. Among authors: bhakta s. Psychopharmacology (Berl). 2012 Feb;219(3):885-96. doi: 10.1007/s00213-011-2417-y. Epub 2011 Aug 16. Psychopharmacology (Berl). 2012. PMID: 21845389
Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia.
Hamilton HK, D'Souza DC, Ford JM, Roach BJ, Kort NS, Ahn KH, Bhakta S, Ranganathan M, Mathalon DH. Hamilton HK, et al. Among authors: bhakta s. Schizophr Res. 2018 Jan;191:87-94. doi: 10.1016/j.schres.2017.06.040. Epub 2017 Jul 12. Schizophr Res. 2018. PMID: 28711472 Free PMC article. Clinical Trial.
355 results